InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Craig Adam R, Chairman & CEO. Insider active across 2 companies, notably CTI Biopharma CORP. Cumulatively, 11 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €27k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 14 August 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
289,881 shares0Common StockSEC:0001628280-25-040441:0
31,470 shares@ US$9.1039.3% of flowCommon StockSEC:0000899243-23-016480:0
83,200 shares@ US$0.84119.6% of flowcommon stockSEC:0000891293-23-000004:0
13,800 shares@ US$0.84111.6% of flowcommon stockSEC:0000891293-23-000002:0
53,996 shares@ US$0.84116.7% of flowcommon stockSEC:0000891293-22-000056:0
242,300 shares@ US$0.841130.1% of flowCommon StockSEC:0000899243-22-031043:0
5,000 shares@ US$5.504.0% of flowcommon stockSEC:0000891293-22-000044:0
Ideal exit: 13 May 2023 (T+270)
6,183 shares@ US$2.11651.9% of flowcommon stockSEC:0000891293-22-000034:0
27,000 shares@ US$0.841147.2% of flowcommon stockSEC:0000891293-22-000027:0
3,178 shares@ US$2.10813.1% of flowCommon StockSEC:0000899243-22-010768:0
5,000 shares@ US$2.12519.8% of flowcommon stockSEC:0000891293-21-000045:0
11 of 11 declarations
About Craig Adam R
Craig Adam R is the President and CEO of CTI Biopharma Corp. He leads the company in developing innovative treatments for blood diseases. His role is crucial in guiding the research and development strategy and ensuring regulatory compliance.
